Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis
other
OA: green
CC0
AI-generated summary
This sensitivity analysis evaluated the impact of dienogest pretreatment on mature oocytes retrieved during IVF-ET procedures, comparing the dienogest group to a non-dienogest control group.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Additional file 4: Figure S4. Sensitivity analysis for mature oocytes in the DNG group versus non-DNG group. DNG, dienogest; CI, confidence interval.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis via openalex
- Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis via openalex
- Dienogest via openalex
- Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
- Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys via openalex
- Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis via openalex
- Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex
- Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest in the treatment of endometriosis via openalex
- Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Effects of Dienogest on Surgically Induced Endometriosis in Rats after Repeated Oral Administration via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- INCIDENCE OF PELVIC ENDOMETRIOSIS IN ROCHESTER, MINNESOTA, 1970–1979 via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone via openalex
- Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
Source provenance
- openalex
- last seen: 2026-05-11T08:34:59.281429+00:00
License: CC0
· commercial use OK